Your browser doesn't support javascript.
loading
Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part II
Castro, Luiz Guilherme Martins; Bakos, Renato Marchiori; Duprat Neto, João Pedreira; Bittencourt, Flávia Vasques; Giacomo, Thais Helena Bello Di; Serpa, Sérgio Schrader; Messina, Maria Cristina de Lorenzo; Loureiro, Walter Refkalefsky; Macarenco, Ricardo Silvestre e Silva; Stolf, Hamilton Ometto; Gontijo, Gabriel.
  • Castro, Luiz Guilherme Martins; Hospital Israelita Albert Einstein. BR
  • Bakos, Renato Marchiori; Hospital Israelita Albert Einstein. BR
  • Duprat Neto, João Pedreira; Hospital Israelita Albert Einstein. BR
  • Bittencourt, Flávia Vasques; Hospital Israelita Albert Einstein. BR
  • Giacomo, Thais Helena Bello Di; Hospital Israelita Albert Einstein. BR
  • Serpa, Sérgio Schrader; Hospital Israelita Albert Einstein. BR
  • Messina, Maria Cristina de Lorenzo; Hospital Israelita Albert Einstein. BR
  • Loureiro, Walter Refkalefsky; Hospital Israelita Albert Einstein. BR
  • Macarenco, Ricardo Silvestre e Silva; Hospital Israelita Albert Einstein. BR
  • Stolf, Hamilton Ometto; Hospital Israelita Albert Einstein. BR
  • Gontijo, Gabriel; Hospital Israelita Albert Einstein. BR
An. bras. dermatol ; 91(1): 49-58, Jan.-Feb. 2016. tab
Article in English | LILACS | ID: lil-776429
ABSTRACT
Abstract The last Brazilian guidelines on melanoma were published in 2002. Development in diagnosis and treatment made updating necessary. The coordinators elaborated ten clinical questions, based on PICO system. A Medline search, according to specific MeSH terms for each of the 10 questions was performed and articles selected were classified from A to D according to level of scientific evidence. Based on the results, recommendations were defined and classified according to scientific strength. The present Guidelines were divided in two parts for editorial and publication reasons. In this second part, the following clinical questions were answered 1) which patients with primary cutaneous melanoma benefit from sentinel lymph node biopsy? 2) Follow-up with body mapping is indicated for which patients? 3) Is preventive excision of acral nevi beneficious to patients? 4) Is preventive excision of giant congenital nevi beneficious to patients? 5) How should stages 0 and I primary cutaneous melanoma patients be followed?.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Skin Neoplasms / Melanoma Type of study: Diagnostic study / Etiology study / Practice guideline Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Israelita Albert Einstein/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Skin Neoplasms / Melanoma Type of study: Diagnostic study / Etiology study / Practice guideline Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Israelita Albert Einstein/BR